Abstract:
A rapid, efficient and convenient method to detect one or more biological entities on a blotting membrane is provided. The detection can relate to the position, nature or amount of the biological substance on one or more membranes. The invention method involves a pressure assisted regiment (such as vacuum or positive gas pressure) for the supply and removal of reagents and permits washing of the contaminants from substances embedded in the membrane to be detected using very low volumes of liquid. This method enables completion of the blocking, washing and antibody binding steps in about 30 minutes without comprising blot quality. In another aspect, the invention is directed to an apparatus useful in conducting the method of the invention. 
     The device is comprised of several layers including a porous support layer below the blotting membrane(s), a flow distributor above the blotting membrane(s) and a well on the flow distributor to contain the liquid to the desired area and to allow for lower starting volumes of such liquid. Preferably, the flow distributor is a non-binding or low binding hydrophilic porous membrane such as a 0.22 micron membrane.

Description:
CROSS-REFERENCE TO RELATED APPLICATIONS 
       [0001]    The present application is at divisional patent application of U.S. application Ser. No. 11/582,727, filed on Oct. 18, 2006 which claims the benefit of U.S. Provisional Application No. 60/795,452, filed on Apr. 27, 2006 and U.S. Provisional Application No 60/732,994, filed on Nov. 3, 2005, incorporated herewith in their entirety. 
         [0002]    The invention relates to a laboratory device and process of using the device to detect the position of or presence/absence of substances that are contained in a blotting membrane. More particularly, it concerns a technique for applying reagents and wash solutions to a blotting membrane to accomplish this detection quickly via the use of a vacuum or positive pressure. 
     
    
     BACKGROUND OF THE INVENTION 
       [0003]    The use of gel electrophoresis is currently the ubiquitous technique for the separation of biological materials. (Nonbiological materials can also be separated using gels or other chromatographic supports as well, but the scope of effort with regard to biologicals is greater.) Typical applications include separation of nucleic acid fragments of various sizes either in the context of sequence determination; in the detection of polymorphisms; or verification of sizes in other contexts. Also frequently conducted are separations of proteins and glycoproteins and application of gel separations as verification of homogeneity or purity. 
         [0004]    In all of these procedures, mixed samples of biological entities are applied to electrophoretic gels and the components are separated by application of an electric field across the gel. Regardless of the manner in which the gel is developed, the resulting pattern of migration of the substances contained in the sample must be detected in some manner. 
         [0005]    To conduct this detection, typically the gel support is contacted with a blotting membrane to which the substances are transferred in the same pattern in which they appeared on the gel. The “spots” are then detected by, at a minimum, by blocking the membrane with a protein or detergent solution to reduce nonspecific binding (which otherwise leads to a high level of noise and low level of detection). Typical blocking agents include casein, bovine serum albumin (BSA), non-fat dry milk (generally about 1%) in a TBS-T or PBS-T solution. The biological entity is then incubated with an antibody specific for the antigen on the membrane. The membrane is then extensively washed to remove any contaminants (such as gel residues), unbound blocking proteins or antibodies and the like. The membrane is then treated and incubated with a secondary enzyme-, radioisotope-, fluorfluor-, or biotin-conjugated antibody specific for the primary antibody. The membrane is then extensively washed again to remove any unbound secondary antibody. Then a detector reagent, generally a chromogenic, chemiluminescent, fluorescent, radiological, or streptavidin-labeled material, is applied which either binds to, or is a substrate of the enzyme-conjugate. Lastly, the appropriate detection device is used to determine the presence, absence position, quantity, etc of the biological entity. The last six steps generally take from 3-6 hours to overnight depending upon the speed of the reaction between the selected reagents, the membrane and the biological entity and the process requires multiple incubation periods of the membrane on a rocking platform. It is a lengthy process that most researchers dislike and which consumes (wastes) a large volume of reagents. 
         [0006]    Some researchers have suggested the use of the capillary action of an absorbent material such as filter paper placed below the membrane to draw the remaining fluids through the membrane and improve the speed of the process especially the washing steps. 
         [0007]    U.S. Pat. No. 5,155,049 mentions a system called the Hybrid-Ease™ hybridization chamber marketed by Hoefer Scientific instruments. This chamber comprises two grids between which the membrane is sandwiched. The grid plates are snapped into position surrounding the membrane, and syringes fitted into the open space created by the grids. One syringe is used to apply reagents and wash, and the other to withdraw excess. The system requires large volumes of liquid in order to operate, is cumbersome to employ and is still quite time consuming. It also mentions that in some particular assays, such as ELISA assays, in small volume wells (such as 96 well microtiter plate), others have used vacuum to draw liquids through one or more membranes in a washing step. However, they discount this effort as it is only available in small volume applications and still is uncontrollable. They suggest instead that the better method is to use a manual press having the membrane on top of a filter paper and cover layer and then pressing the membrane sandwich between two plates to squeeze the liquid through the membrane and into the paper. 
         [0008]    It is clear that a more efficient method for detection of the biological materials or entities on blotting membranes is required. The present invention permits a more effective and efficient detection of biological entities in a blotting membrane. 
       SUMMARY OF THE INVENTION 
       [0009]    A rapid, efficient and convenient method to detect one or more biological entities on a blotting membrane is provided. The detection can relate to the position, nature or amount of the biological substance on one or more membranes. The invention method involves a pressure assisted regiment, selected from positive pressure or a vacuum assisted regiment for the supply and removal of reagents and permits washing of the contaminants from substances embedded in the membrane to be detected using very low volumes of liquid. This method enables completion of the blocking, washing and antibody binding steps in about 30-45 minutes without comprising blot quality. 
         [0010]    Thus, in one aspect, the invention is directed to a method to pass liquid, such as an antibody solution, detection reagent or wash, through one or more membranes in which one or more biological substances to be detected are embedded. The membrane may, for example, correspond to the migration pattern of a sample subjected to separation on an electrophoresis gel. The membrane may also be a specific-binding assay solid support. 
         [0011]    This method is particularly useful for membranes that are obtained by blotting of a gel support which has been used for electrophoretic separation of materials contained in a sample or verification of purity. 
         [0012]    In another aspect, the invention is directed to an apparatus useful in conducting the method of the invention. The device is comprises of several layers including a porous support layer below the one or more layers of blotting membrane, a flow distributor above the blotting membrane(s) and a well on the flow distributor to contain the liquid to the desired area and to allow for lower starting volumes of such liquid. Preferably, the flow distributor is a non-binding or low binding porous membrane such as a 0.22 micron membrane. 
         [0013]    The device has one or more blotting membranes mounted between the flow distributor and the support and is then placed on or into a vacuum manifold of suitable dimensions or a pressure chamber is fit over the top of the flow distributor. The process is then run with the use of vacuum or positive pressure between the necessary steps to move the liquid through the membrane. 
         [0014]    It is an object of the present invention to provide a device for conducting vacuum assisted immunoassays comprising a porous support, a flow distributor placed on top of the porous support and one or more reagent wells mounted on top of the flow distributor. 
         [0015]    It is another object of the present invention to provide a device for conducting positive pressure assisted immunoassays comprising a porous support, a flow distributor placed on top of the porous support and one or more reagent wells mounted on top of the flow distributor. 
         [0016]    It is another object of the present invention to provide a device for conducting vacuum assisted immunoassays comprising a vacuum manifold, porous support mounted on the vacuum manifold, a flow distributor placed on top of the porous support and one or more reagent wells mounted on top of the flow distributor. 
         [0017]    It is a further object of the present invention to provide a device for conducting positive pressure assisted immunoassays comprising a manifold, porous support mounted on the manifold, one or more blotting membranes placed on the porous support, a flow distributor placed on top of the one or more porous membranes, one or more reagent wets mounted on top of the flow distributor and a positive pressure device removably mounted on top of the flow distributor. 
         [0018]    It is a further object of the present invention to provide a process for conducting vacuum assisted immunoassays comprising the steps of:
       a. providing a vacuum manifold, a porous support placed on the vacuum manifold, one or more membranes containing one or more biological entities to be assayed, the membrane being placed on the porous support, a flow distributor placed on top of the membrane and one or more wells placed on top of the flow distributor,   b. adding one or more reagents to the one or more wells and applying a vacuum to pull the reagents into the membrane, and   c. adding one or more washing agents to the one or more wells and applying a vacuum to pull the washing agents and any unbound reagents through the flow distributor, membrane and porous support and into the vacuum manifold.   d. repeating steps (b and c) one or more additional times as desired or required.       
 
         [0023]    It is another object of the present invention to provide a process for conducting vacuum assisted immunoassays comprising the steps of:
       a. providing a vacuum manifold, a porous support placed on the vacuum manifold, one or more membranes containing one or more biological entities to be assayed, the membrane being placed on the porous support, a flow distributor placed on top of the membrane and one or more wells placed on top of the flow distributor,   b. adding one or more reagents to the one or more wells and applying a vacuum to pull the reagents into the membrane,   c. adding one or more washing agents to the one or more wells and applying a vacuum to pull the washing agents and any unbound reagents through the flow distributor, membrane and porous support and into the vacuum manifold, and   d. repeating steps (b and c) one or more additional times.       
 
         [0028]    It is an object of the present invention to provide a process of passing a wash or reagent-containing liquid through a blotting membrane containing one or more biological entities, at least one of which is to be detected wherein the process comprises:
       a. providing a vacuum manifold, a porous support placed on the vacuum manifold, a flow distributor and one or more wells placed on top of the flow distributor,   b. placing the one or more blotting membranes containing the one or more biological entities on the porous support,   c. placing the flow distributor on top of the blotting membrane(s),   d. adding a liquid to the well of the flow distributor, and applying a vacuum to draw the liquid through the flow distributor, blotting membrane(s) and porous support into the manifold.       
 
         [0033]    It is an object of the present invention to provide a process of passing a wash or reagent-containing liquid through one or more blotting membranes containing one or more biological entities, at least one of which is to be detected wherein the process comprises:
       a. providing a manifold, a porous support pieced on the manifold, a flow distributor and one or more wells placed on top of the flow distributor,   b. placing the one or more blotting membranes containing the one or more biological entities on the porous support,   c. placing the flow distributor on top of the blotting membrane(s),   d. adding a liquid to the well of the flow distributor, and applying a positive pressure to the flow distributor to move the liquid through the flow distributor, blotting membrane(s) and porous support to the manifold.       
 
     
    
     
       IN THE DRAWINGS 
         [0038]      FIG. 1  shows a first embodiment of a device according to the present invention in cross-sectional view. 
           [0039]      FIG. 2  shows a second embodiment of a device according to the present invention in cross-sectional view. 
           [0040]      FIG. 3  shows a third embodiment of a device according to the present invention in cross-sectional view. 
           [0041]      FIG. 4  shows a fourth embodiment of a device according to the present invention in cross-sectional view. 
           [0042]      FIGS. 5A-5C  show the embodiments of the process according to the present invention in block diagram form. 
           [0043]      FIG. 6  shows the results of an example of a blot processed according to the prior art and the current invention. 
       
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
       [0044]    In order to accomplish the present invention a device according to the present invention is used. As shown in  FIG. 1 , the device  2  is comprised of a porous support  4 . Preferably the support is formed with an edge  6  or mounting piece that is designed to fit into or onto a manifold  8  (described below). One or more layers of a blotting membrane  10  are placed on top of the support  4 . A flow distributor  12  is then placed or mounted on top of the blotting membrane  10 . The flow distributor may if desired either have one or more wells  14  (one shown in this embodiment) attached to the top surface  16  of the flow distributor  12  or it may be a separate piece (not shown) which is simply attached or placed on top of the flow distributor  12 . 
         [0045]    As shown in  FIG. 1 , the manifold  8  in this embodiment is a vacuum manifold which has a port  18  that is attached to a source vacuum  20 . Alternatively, positive pressure (to be described further below) can be used instead of a vacuum to drive the filtration/washing process. The port  18  is located below the porous support  4 . A waste collection device  22 , in this instance, a receptacle, is mounted below the manifold or if desired in the manifold (not shown) to collect the liquid pulled through the device  2 . Alternatively, the waste collection device can be a waste drain or other similar device as is known to one of ordinary skill in the art. 
         [0046]    The flow distributor  12  is a porous structure. In one embodiment (shown) the entire structure is porous. In another embodiment shown in  FIG. 2 , the flow distributor  12 A is only porous in the area  24  within the well(s)  14 . The area  17  of the distributor  12  that is non-porous can be rendered so by filling the pores in that area  17  with a non-porous material such as a plastic or a glue, by collapsing the pores in that area  17  with heat and/or pressure and/or solvents as is well known in the art or by forming the distributor  12  to match the size of the outer dimension of the well(s)  14  and liquid tightly sealing the distributor  12  to the bottom of the well(s)  14  along its outer dimension. 
         [0047]    The flow distributor  12  may be any porous structure that provides for even distribution of the liquid across its face and which is sufficiently porous to allow for easy movement under the influence of a vacuum and which is also capable of filtering out agglomerates, particles and other debris from the liquid. 
         [0048]    The flow distributor may be of any desired size. Gels come in a variety of “standard” sizes from about 7 cm by 8 cm to a 20 cm by 20 cm area. 
         [0049]    Such materials include but are not limited to woven, non-woven and fibrous porous filters such as TYVEK® or TYPAR® paper, cellulosic materials such as MILLISTAK+® filters available from Millipore Corporation of Billerica, Mass., membranes such as microporous membranes, sintered membranes such as POREX® filters and the like. Preferred are membranes, especially plastic microporous membranes. 
         [0050]    A preferred pore size of such membranes is between about 0.1 and about 0.65 micrometer, preferably between 0.2 and about 0.45 micrometer and more preferably about 0.22 micrometer, 
         [0051]    Additionally, the preferred filter or membrane has low binding characteristics for the reagents used in order to minimize the amount used. More preferably, as it is generally used with biological materials it is hydrophilic and has low protein binding characteristics. One such distributor is a hydrophilic DURAPORE® membrane formed of PVDF available from Millipore Corporation of Billerica, Mass. Another is a Millipore EXPRESS® hydrophilic PES membrane available from Millipore Corporation of Billerica, Mass. 
         [0052]    The porous support  4  may be a simple screen, a grid, or a sintered porous structure such as a POREX® membrane or a coarse or large pored microporous filter, such as a non-woven paper polypropylene or polyethylene fabric or a 1-10 micron microporous filter. Such supports can be made of polymer, ceramic or metal materials including but not limited to metals, such as stainless steel, steel a steel alloy, aluminum and the like, and polymers such as polyethylene, polypropylene, polysulfones styrenes, nylons and the like. 
         [0053]      FIG. 3  shows an embodiment using a standard vacuum manifold  30 . In this instance the manifold has porous support structure  32 , such as a plastic of metal grid or a porous sintered sheet of plastic or metal or other similar devices as are well known in the vacuum art. The blotting membrane  34  is again placed on top of the support  32 , covered by the flow distributor  36  and a well structure  38  as described above in relation to the embodiments of  FIGS. 1 and 2 . 
         [0054]      FIG. 4  shows a positive pressure system that may be used in the present invention. To the extent the elements are the same as those in  FIGS. 1-3 , the same reference numbers have been used. 
         [0055]    As shown in  FIG. 4 , the device  24  is comprised of a porous support  4 . Preferably the support is formed with an edge  6  or mounting piece that is designed to fit into or onto a manifold  8 . One or more layers of a blotting membrane  10  (one shown) are placed on top of the support  4 . A flow distributor  12  is then placed or mounted on too of the blotting membrane  10 . The flow distributor may either have one or more wells  14  (one shown in this embodiment) attached to the top surface  16  of the flow distributor  12  or it may be a separate piece (not shown) which is simply attached or placed on top of the flow distributor  12 . A positive pressure manifold or cover  13  is placed over and preferably removably secured to the wells  14  and/or flow distributor  12 . The positive pressure manifold  13  has a port  15  connected to a source of positive pressure via tube  17 . Positive pressure may come from a pump, a pressurized gas supply (tank, canister or the like) and other such well known sources used in the lab or industry. 
         [0056]    As shown in  FIG. 4 , the manifold  8  is simply a collection manifold which has a port  18  that can be used to vent excess pressure. It may if desired contain an air filter to prevent the entrance of contaminants. The port  18  is located below the porous support  4 . A waste collection device  22 , in this instance, a receptacle, is mounted below the manifold or if desired in the manifold not shown) to collect the liquid pulled through the device  2 . Alternatively, the waste collection device can be a waste drain or other similar device as is known to one of ordinary skill in the art. 
         [0057]    Various methods may be used in the present invention. The key factor being that they all rely on a vacuum or positive pressure driven filtration of the liquids rather than static diffusion as has occurred in the past. 
         [0058]    The simplest method is to simply use the present invention to conduct one or more of the washing cycles. Typically each washing cycle is comprised of one or more washing steps. Generally, 2-5 steps are used per cycle. 
         [0059]    Another method is to use the present invention in each step in which liquid needs to be removed from the blotting membrane such as after incubation of the antibodies or in the washing steps. 
         [0060]    In a of these processes, any pressure suitable to move the liquid(s) through the device and into the manifold can be used. This can vary depending upon the membranes selected for blotting and the flow distributor, the manifold used, the desired speed of the filtration and the supply of vacuum or positive pressure available to the researcher. 
         [0061]    Generally, the vacuum available may vary between 100 and 760 mm Hg (133 millibars and 1013 millibars). The use of valves, pressure restrictors and the like may also be used to keep the vacuum within the allowed ranges for the membranes used. A preferred vacuum manifold of one embodiment of the present invention is a STERICUP® device vacuum base and the use of a vacuum of about 100 mm Hg. Other suitable vacuum manifolds include but are not limited to the MULTISCREEN™ and MULTISCREEN HTS  vacuum manifolds available from Millipore corporation of Billerica, Mass. 
         [0062]    Generally the positive pressure is supplied by an air line at pressures ranging from about 2 psi to about 15 psi. The use of valves, pressure restrictors and the like may also be used to keep the pressure within the allowed ranges for the membranes used. Such pressure systems include but are not limited to Amicon® stirred cell devices available from Millipore Corporation of Billerica, Mass. and positive pressure filtration units available from Caliper Life Sciences of Hopkinton, Mass. 
         [0063]    Typical processes are shown in  FIGS. 5A-C  in block diagram. 
         [0064]    In  FIG. 5A , a device according to the invention is provided and attached to a vacuum manifold and vacuum supply  50 . The blotting membrane(s) are placed into the device in the proper position  52 . Preferably the blotting membrane(s) in step  52  has been prewet (not shown). The vacuum is turned on and a liquid, such as with a wash liquid, is placed into the well(s)  54 . The vacuum continues until the liquid has been drawn through the device and then the vacuum is turned off  56 . When more than one blotting membrane is used, they can be arranged in series on top of each other and sufficient liquid containing the same desired reagents can be easily moved through the multiple layers in one process step. Generally when more than one layer is used it is preferred that one use between 2 and 10 layers, preferably between 2 and 5 layers at a time. Alternatively, one can use a flow distributor having multiple wells and use more than one blotting membrane in parallel to each other, each with their own well in the flow distributor and each with its own set of reagents as is required for its specific purpose. One can even use multiple layers in adjacent wells if desired. 
         [0065]    In  FIG. 5B , step  54  is eliminated and the liquid is added with the vacuum off  58  and allowed to incubate, such as may be required with the primary or secondary antibodies. The vacuum is then turned on in step  60 . 
         [0066]    In  FIG. 55C , the steps of  55 A and  55 B are combined as sequential steps. Either or both steps may be repeated as needed or arranged in different sequences as desired to conduct the appropriate process. 
         [0067]    Optionally, if one wishes, one can place a pan or single well device below the support of the membrane, preferably in the manifold itself. It can then be used to collect a single unbound reagent that may be expensive and which can be reused in future assays. Optionally, it may be subdivided into two or more subtrays. 
         [0068]    Other processes may also be used with the device of the present invention. 
         [0069]    Although the antibody concentrations used vary depending on the experimental design, 10-1,000 ng/mL is a typical range for standard method. Volumes of solution required are typically 0.1 mL/cm 2 , 0.03 mL/cm 2  and 1.0 mL/cm 2  for blocking, antibody reactions and washing respectively. 
         [0070]    The membrane contains, in its interstices, one or more substances to be detected. Generally these substances are present in the interstices either by virtue of having been blotted from a solid support for electrophoresis or chromatography or by direct application, usually to detect the presence, absence, or amount of a particular type of material such as an antibody or specific protein—i.e. a Dot-Blot type assay as described above. The definition of the membrane is not limited, however, to these instances, but applies to any case wherein one or more membranes contains in its interstices one or more substances to be detected. Included in the types of membranes envisioned for use in the present invention are membranes commonly used to blot electrophoresis gels such as nitrocellulose; nylon; or various other polymeric membranes, such as polyvinylidene fluoride (PVDF), sold as Immobilon™ membranes by Millipore Corporation of Billerica, Mass. 
         [0071]    A variety of materials can be used to replicate the results of electrophoresis gels performed on various samples as is understood in the art. Most commonly, the samples contain biological substances such as individual proteins, antibodies, nucleic acids, oligonucleotides, complex carbohydrates, and the like, but the application of the technique is not limited to these substances. The invention technique is applicable to any membrane containing within it a substance to be detected regardless of the chemical composition of the membrane or of the target substances. 
         [0072]    When membranes which represent replicas of electrophoretic results are employed, the transfer of the substances to be detected from the gel to the membrane can be conducted by utilizing membranes containing transfer buffer, by electroelution, electroblotting or by semi-dry blotting of the gels. Techniques for these transfers are well understood in the art, and do not constitute part of the invention herein. 
         [0073]    The liquid to be supplied may contain detecting reagent or may simply be provided as a wash. The nature of the detecting reagent depends, of course, on the substance to be detected. Typically, proteins are detected by immunological reactions between antigen and antibody or immunoreactive portions thereof; typically the presence of nucleic acid fragments is detected by suitable oligonucleotide probes. The detecting substances responsible for the immediate or specific reaction with the substance to be detected may be further supplemented, if needed, with label and a multiplicity of applications of the detecting reagents may be needed—e.g., a protocol may include detection of an antigen by supplying an antibody labeled with an enzyme, e.g., commonly, horseradish peroxidase, and then this binding is detected by means of supplying substrate for this enzyme. In application of reagent, it is possible, though not preferred, to use only a positively pressed donor matrix to expose this component of the membrane for a defined period. 
         [0074]    It is most convenient to conduct the method of the invention at room temperature, but elevated and tower temperatures can also be used. This can be affected by heating the device or its surrounding environment (as in a heat box or cooling box). 
         [0075]    Blots can be sequentially analyzed with multiple antibodies or probes in the present device and process by stripping the previously hound antibodies from the blot followed by subsequent incubations with antibodies or other probes specific other target proteins. The stripping process disrupts the antigen-antibody bonds and dissolves the antibodies in the surrounding buffer. This is usually achieved by a combination of detergent and heat or by exposure to either high or low pH. The device, in combination with the flow distributor, enables the stripping of blots using the high or low pH method. The subsequent reprobing of blots either directly (e.g., using the same flow distributor used for striping) or subsequently after storage, would use the same protocol as the initial probing. Suitable kits for strip blotting are available from Chemicon International Inc under the brand names of ReBlot Plus kit (catalogue #2500), Re-Blot Plus-Mild solution (catalogue #2502) and Re-Blot Plus-Strong solution (catalogue #2504). 
         [0076]    In standard western blotting. the antigen or target is transferred to one or more membranes support and probed with a suitable probe such as an antibody, protein (e.g., Protein A) or lectin (proteins or glycoproteins which binding to carbohydrate moieties). In some applications, a reverse format (e.g., reverse array) is used, wherein the antibody or other probes are spotted onto one or more membranes or other support (typically in an array format) and the antigen or target is presented to the immobilized antibodies on the array. Visualization of a target-probe binding event can be achieved by labeling of the antigens or targets or by using a secondary antibody specific for the target. Reverse arrays often employ mixtures of targets, for example lysates labeled with different fluorescent colors to enable parallel processing. Reverse assays can also be performed with the present invention. 
       EXAMPLE 
       [0077]    The device of  FIG. 1  was made using the base of a STERICUP® device (available from Millipore Corporation of Billerica, Mass.) as the vacuum manifold, a piece of Porex® porous plastic as the porous support, a Durapore® hydrophilic membrane (GVPP), 0.22 micron pore size as the flow distributor and a polystryrene strip (typically 4 mm larger than the membrane size. For example, 76 mm (L)×86 mm (W)×25 mm (H) for 72 mm×82 mm) well formed by bending the strip at 90° to form four corners and sealing the ends of the strip to each other using ( 3211  light cure adhesive, available from Loctite). The well was glued to the membrane surface using the Loctite  3211  light cure adhesive. 
         [0078]    The base was connected to a valved vacuum line via its vacuum port. 
         [0079]    A prewet (prewet in 100% methanol, then in water) blotting membrane (IMMOBILON™ Western blotting membrane available from Millipore Corporation of Billerica, Mass.) containing a sample of bovine liver lysate was placed on the base and all air bubbles between the base and membrane were removed. The flow distributor was placed on top of the blotting membrane. All air bubbles between the base and membrane were removed. A vacuum of 100 mm Hg was applied and Then  10  mL of a blocking solution (1% casein in TBS-T (Tris buffered saline and Tween™-20 surfactant: 20 mM Tris-CL, pH7.6, 0.8% sodium chloride, 0.1% Tween®-20 surfactant) was added to the well. The vacuum was then shut off. 1 mL of a diluted rabbit anti-ERK primary antibody (diluted 1:2,000 with 1% casein in TBS-T) was added to the well and allowed to incubate for 10 minutes without any vacuum. A vacuum of 100 mm Hg was applied to filter the remaining antibody liquid. 30 mL of a TBS-T washing solution was added and filtered under vacuum. (until dryness). Three additional washes each, 30 mL of a TBS-T washing solution, were added sequentially and filtered under vacuum. The vacuum was then turned off and 1 mL of a diluted secondary antibody (alkaline phosphate conjugated goat anti-rabbit IgG antibody) (diluted 1:1000 with 1% casein in TBS-T) was added to the well and allowed to incubate for 10 minutes without vacuum. The vacuum was then applied at 100 mm Hg to filter the remaining secondary antibody solution through the flow distributor. Four sequential washes each of 30 mL of a TBS-T washing solution were added and filtered under vacuum and then the vacuum was shut off. A substrate (Immobilon™ Western AP reagent) was added to the well and a detection. The membrane was exposed to an X-ray film for 1 minute and the film was processed by a film developer was completed. 
         [0080]    A comparative example using the traditional methodology and the same type of membrane, protein (ERK) and reagents was performed in over 3 hours of time.
       1. Block the membrane in 1% casein/TBS-T for 1 h (0.1 mL/cm 2  membrane)   2. Add Anti-ERK antibody (1:10,000 dilution with 1% casein in TBS-T) for 1 h (0.1 mL/cm 2  membrane)   3. Wash four times for 5 minutes in TBS-T (1.0 mL/cm 2  membrane)   4. Add secondary antibody (anti-rabbit IgG alkaline phosphatase conjugated at 1:5,000 dilution with 1% casein in TBS-T) for 1 h (0.1 mL/cm 2  membrane)   5. Wash four times for 5 minutes in TBS-T (1.0 mL/cm 2  membrane)   6. Add Immobilon™ Western AP reagent and incubate for 5 minutes (0.05 mL/cm 2  membrane)     7 . Expose to X-ray film for 1 minute Then proceed to film development       
 
         [0088]      FIG. 6  shows the comparative example and the example according to the device and process of the present invention. The Figure demonstrates the high quality detection that can be achieved in only 30 minutes. In addition, the amount of antibodies used as compared to the traditional process was reduced by half in the process of the present invention in spite of the 5× increase in concentration in 1/10 th  volume of the traditional example. This not only allows researchers to do more experiments but to do so with less reagents and higher quality results. Moreover, the background no was significantly reduced as compared to the traditional method.